Ángel Luis
Montejo González
Profesor Titular de Universidad
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (67)
2024
-
Switching to Vortioxetine in Patients with Poorly Tolerated Antidepressant-Related Sexual Dysfunction in Clinical Practice: A 3-Month Prospective Real-Life Study
Journal of Clinical Medicine, Vol. 13, Núm. 2
2020
-
Consensus on recommendations for safe sexual activity during the covid-19 coronavirus pandemic
Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-12
2019
-
A Real-World Study on Antidepressant-Associated Sexual Dysfunction in 2144 Outpatients: The SALSEX I Study
Archives of Sexual Behavior, Vol. 48, Núm. 3, pp. 923-933
-
Frequency of sexual dysfunction in patients treated with desvenlafaxine: A prospective naturalistic study
Journal of Clinical Medicine, Vol. 8, Núm. 5
-
Hormonal contraceptives, female sexual dysfunction, and managing strategies: A review
Journal of Clinical Medicine, Vol. 8, Núm. 6
-
Online porn addiction: What we know and what we don’t—a systematic review
Journal of Clinical Medicine, Vol. 8, Núm. 1
-
Re: Sexual Dysfunction and Quality of Life in Chronic Heroin-Dependent Individuals on Methadone Maintenance Treatment
Journal of Urology
-
Sexual dysfunction and quality of life in chronic heroin-dependent individuals on methadone maintenance treatment
Journal of Clinical Medicine, Vol. 8, Núm. 3
-
Understanding the mechanism of antidepressant-related sexual dysfunction: Inhibition of tyrosine hydroxylase in dopaminergic neurons after treatment with paroxetine but not with agomelatine in male rats
Journal of Clinical Medicine, Vol. 8, Núm. 2
2018
-
Clinically significant personality traits in individuals at high risk of developing psychosis
Psychiatry Research, Vol. 261, pp. 498-503
-
Influence of personality traits on the severity of alcohol use disorders
Journal of Clinical Medicine, Vol. 7, Núm. 6
-
The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management
World Psychiatry, Vol. 17, Núm. 1, pp. 3-11
2017
-
Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics
Frontiers in Neuroendocrinology, Vol. 45, pp. 25-34
-
Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off values
Schizophrenia Research, Vol. 189, pp. 69-74
2016
-
Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos
Revista de Psiquiatria y Salud Mental
2015
-
Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale
Journal of Psychopharmacology
-
Sexual side-effects of antidepressant and antipsychotic drugs
Current Opinion in Psychiatry, Vol. 28, Núm. 6, pp. 418-423
2013
-
Sexuality and obsessive-compulsive disorder: The hidden affair
Neuropsychiatry, Vol. 3, Núm. 1, pp. 23-31
-
Systematic depression screening in high-risk patients attending primary care: A pragmatic cluster-randomized trial
BMC Psychiatry, Vol. 13, Núm. 1
2012
-
Ziprasidone versus olanzapine in the weight gain associated with the treatment of schizophrenia: A six-month double-blind randomized parallel group study
European Journal of Psychiatry, Vol. 26, Núm. 4, pp. 248-259